174 related articles for article (PubMed ID: 22806406)
1. Following the concentration of polymeric nanoparticles during nebulization.
Beck-Broichsitter M; Knuedeler MC; Schmehl T; Seeger W
Pharm Res; 2013 Jan; 30(1):16-24. PubMed ID: 22806406
[TBL] [Abstract][Full Text] [Related]
2. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
[TBL] [Abstract][Full Text] [Related]
3. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions.
Beck-Broichsitter M; Knuedeler MC; Oesterheld N; Seeger W; Schmehl T
Int J Pharm; 2014 Jan; 459(1-2):23-9. PubMed ID: 24286921
[TBL] [Abstract][Full Text] [Related]
4. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
[TBL] [Abstract][Full Text] [Related]
5. Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance.
Dalla-Bona AC; Schmehl T; Gessler T; Seeger W; Beck-Broichsitter M
Drug Dev Ind Pharm; 2015; 41(10):1704-9. PubMed ID: 25519975
[TBL] [Abstract][Full Text] [Related]
6. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features.
Dailey LA; Schmehl T; Gessler T; Wittmar M; Grimminger F; Seeger W; Kissel T
J Control Release; 2003 Jan; 86(1):131-44. PubMed ID: 12490379
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
[TBL] [Abstract][Full Text] [Related]
8. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.
Dailey LA; Kleemann E; Wittmar M; Gessler T; Schmehl T; Roberts C; Seeger W; Kissel T
Pharm Res; 2003 Dec; 20(12):2011-20. PubMed ID: 14725368
[TBL] [Abstract][Full Text] [Related]
9. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
[TBL] [Abstract][Full Text] [Related]
10. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S
Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949
[TBL] [Abstract][Full Text] [Related]
11. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.
Nguyen J; Steele TW; Merkel O; Reul R; Kissel T
J Control Release; 2008 Dec; 132(3):243-51. PubMed ID: 18619502
[TBL] [Abstract][Full Text] [Related]
12. Magnetic core-shell nanoparticles for drug delivery by nebulization.
Verma NK; Crosbie-Staunton K; Satti A; Gallagher S; Ryan KB; Doody T; McAtamney C; MacLoughlin R; Galvin P; Burke CS; Volkov Y; Gun'ko YK
J Nanobiotechnology; 2013 Jan; 11():1. PubMed ID: 23343139
[TBL] [Abstract][Full Text] [Related]
13. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
[TBL] [Abstract][Full Text] [Related]
14. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
[TBL] [Abstract][Full Text] [Related]
15. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
16. Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.
Hanna LA; Basalious EB; ELGazayerly ON
Drug Deliv; 2016 Nov; 24(1):188-198. PubMed ID: 28156176
[TBL] [Abstract][Full Text] [Related]
17. Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles.
Aragao-Santiago L; Hillaireau H; Grabowski N; Mura S; Nascimento TL; Dufort S; Coll JL; Tsapis N; Fattal E
Nanotoxicology; 2016; 10(3):292-302. PubMed ID: 26573338
[TBL] [Abstract][Full Text] [Related]
18. Nebulized coenzyme Q
Rossi I; Sonvico F; McConville JT; Rossi F; Fröhlich E; Zellnitz S; Rossi A; Del Favero E; Bettini R; Buttini F
Eur J Pharm Sci; 2018 Feb; 113():159-170. PubMed ID: 29066385
[TBL] [Abstract][Full Text] [Related]
19. Nebulization of active pharmaceutical ingredients with the eFlow(®) rapid: impact of formulation variables on aerodynamic characteristics.
Beck-Broichsitter M; Prüfer N; Oesterheld N; Seeger W; Schmehl T
J Pharm Sci; 2014 Aug; 103(8):2585-9. PubMed ID: 24986144
[TBL] [Abstract][Full Text] [Related]
20. Electrolyte type and nozzle composition affect the process of vibrating-membrane nebulization.
Beck-Broichsitter M; Oesterheld N
Eur J Pharm Biopharm; 2017 Oct; 119():11-16. PubMed ID: 28499855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
